Technical Analysis for IPIX - Innovation Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade F 0.1255 -9.65% -0.0134
IPIX closed down 9.65 percent on Friday, September 20, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical IPIX trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
200 DMA Resistance Bearish -9.65%
50 DMA Resistance Bearish -9.65%
Shooting Star Candlestick Bearish -9.65%
20 DMA Support Bullish -9.65%
Bollinger Band Squeeze Range Contraction -9.65%
Wide Range Bar Range Expansion -9.65%
BB Squeeze + Upper Band Touch Range Contraction -9.65%
Upper Bollinger Band Touch Strength -9.65%

Older signals for IPIX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. The company's lead drug compound is Brilacidin, which is in Phase II study for the treatment of oral mucositis, inflammatory bowel disease, and acute bacterial skin and skin structure infection. It also develops Prurisol, a Phase IIb compound, which is in development for psoriasis; and Kevetrin, a lead anti-cancer compound for treating ovarian cancer. In addition, the company owns other candidates for treating diseases, including autism, arthritis, asthma, MS/ALS/Parkinson's, cancer, hypertensive emergency, and bacterial and fungal infections. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Beverly, Massachusetts.
Health Biotechnology Cancer Pharmaceutical Industry Biopharmaceutical Life Sciences Pharmacy Diseases Arthritis Asthma Psoriasis Stage Biopharmaceutical Ovarian Cancer Inflammatory Diseases Inflammatory Bowel Disease Specialty Drugs Ms Parkinson's Autism Als Oral Mucositis Small Molecule Therapies
Is IPIX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 0.4351
52 Week Low 0.07
Average Volume 386,920
200-Day Moving Average 0.1531
50-Day Moving Average 0.144
20-Day Moving Average 0.1302
10-Day Moving Average 0.1329
Average True Range 0.0184
ADX 19.97
+DI 29.1326
-DI 10.8907
Chandelier Exit (Long, 3 ATRs ) 0.1248
Chandelier Exit (Short, 3 ATRs ) 0.1692
Upper Bollinger Band 0.1413
Lower Bollinger Band 0.1191
Percent B (%b) 0.29
BandWidth 17.050691
MACD Line -0.0029
MACD Signal Line -0.0044
MACD Histogram 0.0016
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1555
Resistance 3 (R3) 0.1570 0.1485 0.1505
Resistance 2 (R2) 0.1485 0.1409 0.1478 0.1488
Resistance 1 (R1) 0.1370 0.1361 0.1328 0.1355 0.1472
Pivot Point 0.1285 0.1285 0.1264 0.1278 0.1285
Support 1 (S1) 0.1170 0.1209 0.1128 0.1155 0.1038
Support 2 (S2) 0.1085 0.1161 0.1078 0.1022
Support 3 (S3) 0.0970 0.1085 0.1005
Support 4 (S4) 0.0955